This activity, hosted by Shannon Westin, MD, presents the most up-to-date information on PARP inhibitor use, dosing, toxicities, and FDA approvals. By the end of this webinar, attendees will be able to:

• Recognize the rationale for use of a PARP inhibitor
• Identify drugs, label, and FDA approvals for use
• Examine existing studies and evaluate results
• Examine treatment regimens based on dosing recommendations and anticipated results
• Identify common toxicities and how they are managed
• Understand use of PARP inhibitors in maintenance therapy

Recorded in August 2019. 

Keywords: BRCA, Ovary, PARPi, Maintenance